Skip to content
Clinical Trials – home
BulgariaBack to Bulgaria

Clinical trials in Pleven – page 2

300 clinical trials in Pleven, Bulgaria across 2 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.

Pleven at a glance
300
clinical trials
  • Research sites2
Type of trial
Recruitment status
Quick filters

300 trials in Pleven

Open in trial search

Study of SPN-817 (Huperzine A) in Adults with Focal Onset Seizures: Testing Safety and Effectiveness of Treatment

Investigational
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:Huperzine A
  • Sponsor:Supernus Pharmaceuticals Inc.

Study of trospium chloride and xanomeline tartrate combination for agitation in Alzheimer's disease patients: Long-term safety evaluation

InvestigationalNo placebo
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:Trospium Chloride
  • Sponsor:Bristol-Myers Squibb Services Unlimited Company

Vitiligo+2

Recruiting

Long-term safety study of oral povorcitinib in patients with hidradenitis suppurativa, prurigo nodularis, or vitiligo who previously participated in clinical trials

InvestigationalNo placebo
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:Povorcitinib
  • Sponsor:Incyte Corp.

Study of vicadrostat and empagliflozin combination in patients with type 2 diabetes, high blood pressure and cardiovascular disease

Registered drug
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:BI 690517
  • Sponsor:Boehringer Ingelheim Espana S.A.

Cardiac failure

Recruiting

Study of PF-07328948 tablets compared to placebo in adults with heart failure to evaluate effects on symptoms and physical function

Investigational
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:PF-07328948
  • Sponsor:Pfizer Inc.

Study on ITI-1284 for Patients with Generalized Anxiety Disorder Who Did Not Respond Well to Previous Treatments

Investigational
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:ITI-1284
  • Sponsor:Intra-Cellular Therapies Inc.

Study of Zasocitinib and Apremilast for Adults with Active Psoriatic Arthritis Who Have Not Used Biologic Medicines

Registered drug
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:Apremilast
  • Sponsor:Takeda Development Center Americas Inc.
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:Baxdrostat
  • Sponsor:AstraZeneca AB

Study on Tozorakimab for Patients Hospitalized with Severe Viral Lung Infections Needing Oxygen

Investigational
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:Tozorakimab
  • Sponsor:AstraZeneca AB

Study on Lebrikizumab for Adults with Chronic Rhinosinusitis and Nasal Polyps Using Intranasal Corticosteroids

Registered drug
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:Lebrikizumab
  • Sponsor:Eli Lilly & Co.

Cardiac failure

Recruiting

Study on BI 690517 and Empagliflozin for Patients with Heart Failure and Preserved Ejection Fraction

Registered drug
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:BI 690517
  • Sponsor:Boehringer Ingelheim International GmbH

Study on Selatogrel for Preventing Heart Attack in Patients with Recent Heart Attack History

Investigational
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:Selatogrel
  • Sponsor:Viatris Innovation GmbH

Other cities in Bulgaria

The busiest research cities in the country

All 53 cities in Bulgaria

Clinical research in Pleven

What the registry says about research in the country

01 Respiratory Health

Innovative research focusing on viral respiratory infections, including studies of vaccines against RSV, human metapneumovirus, and influenza in older adults. Clinical trials aim to enhance protection against severe respiratory diseases.

  • RSV and hMPV Prevention
  • Influenza Vaccine Development
  • Viral Lung Infection Treatment

Emphasis on vaccine efficacy and immune response in vulnerable populations.

02 Dermatological Conditions

Comprehensive studies addressing various skin conditions, with particular focus on psoriasis and hidradenitis suppurativa. Research includes both systemic and targeted therapies.

  • Plaque Psoriasis Management
  • Hidradenitis Suppurativa Treatment
  • Genital Psoriasis Therapy

Innovative approaches in chronic skin condition management.

03 Cardiovascular Research

Advanced studies in cardiovascular disease prevention and treatment, including investigations into heart failure prevention and lipid management strategies.

  • Heart Failure Prevention
  • Lipoprotein Management
  • Cardiovascular Risk Reduction

Focus on preventive strategies and innovative therapeutic approaches.

04 Autoimmune Disorders

Investigations into various autoimmune conditions, including multiple sclerosis and Sjögren's disease, exploring new therapeutic options and treatment approaches.

  • Multiple Sclerosis Treatment
  • Sjögren's Disease Management
  • Inflammatory Disease Therapy

Emphasis on improving quality of life for patients with chronic conditions.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.